Swiss company Novartis argued in India’s Supreme Court that it was entitled to a patent for the amended version of cancer drug Glivec because the original compound was not suited to be turned into a pill. Photograph: Reuters

India’s Supreme Court has rejected a plea by Swiss pharmaceutical manufacturer Novartis AG to patent an updated version of its cancer drug Gliv(...)